SBIR Phase I: Mitigating the effects of isolation and absence of therapies through the delivery of cloud based digital treatments and remote patient monitoring
SBIR 第一阶段:通过提供基于云的数字治疗和远程患者监控来减轻隔离和缺乏治疗的影响
基本信息
- 批准号:2036451
- 负责人:
- 金额:$ 25.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Standard Grant
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-03-01 至 2022-02-28
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to improve the quality of life for the more than 1 million Americans currently suffering from Parkinson’s Disease (PD) while reducing the growing economic burden on the healthcare system. Outpatient physical and occupational therapy, speech therapy, and mental health are key components in the treatment and management of PD. Early intervention and appropriate symptomatic management utilizing these therapies is essential for best long-term outcomes; Inadequate and infrequent treatment, especially during the COVID-19 pandemic, places a heavier burden on Person with Parkinson’s (PwP) and their families and a greater financial burden on the healthcare system. Delivering remote therapies and monitoring performance via the proposed in-home therapy platform may demonstrate a reduction in symptoms or slowing of disease progression, thereby helping to reduce costly, adverse medical complications and improving the PwP quality of life. Data collected from regular in-home, daily therapies may lead to improved standards of care and aid the research community in the search for a cure. Once proven effective in the beachhead market of PD, the technology could be trialed in the mainstream markets of Alzheimer’s, Dementia, and the aging population. This Small Business Innovation Research (SBIR) Phase I project will develop a prototype for an automated therapy delivery and remote patient monitoring platform for those suffering from Parkinson’s Disease (PD). This automated platform will provide access to daily therapies for the Person with Parkinson’s (PwP) by facilitating remote therapeutic exercise and social engagement via an in-home device that monitors real-time functionality to adapt cloud based digital content to optimize physical performance, cognition, and physiological response to exercise and cognitive tasks. Such a therapeutic system should have similar levels of efficacy as in-person therapy and treatment sessions, enabling participation in the much needed therapies while simultaneously reducing the burdens placed on the PwP, their families, and the healthcare system. The subjective report data, physiological response data, and objective performance data collected throughout each session will be summarized in a report for the PwP, their families, and their caregivers or healthcare providers to improve the continued delivery of treatment, clinical decision making, and health and safety of the patient. This proposed technology will help to reduce the effects of isolation, provide access to physical therapy and exercise treatments and improve the remote monitoring of patients throughout the COVID-19 pandemic crisis and beyond.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
这项小型企业创新研究(SBIR)I阶段项目的更广泛的影响/商业潜力是改善目前患有帕金森氏病(PD)的100万美国人的生活质量,同时减少医疗保健系统上日益增长的经济燃烧。门诊身体和占领疗法,言语疗法和心理健康是PD治疗和管理的关键组成部分。使用这些疗法的早期干预和适当的症状管理对于最佳的长期结局至关重要;不足和不经常治疗,尤其是在19日大流行期间,与帕金森氏症(PWP)及其家人的人烧毁了较重的烧伤,并对医疗保健系统的财务燃烧更大。通过拟议的家庭疗法平台提供远程疗法和监测性能可能会显示出症状的减少或疾病进展的减慢,从而有助于减少昂贵,不良的医疗并发症并改善PWP生活质量。从常规内部,每日疗法收集的数据可能会提高护理标准,并帮助研究社区寻求治愈。一旦被证明在PD的Beachhead市场中有效,该技术就可以在阿尔茨海默氏症,痴呆症和老龄化人口的主流市场中进行试用。这项小型企业创新研究(SBIR)I期项目将为患有帕金森氏病(PD)的人开发一个原型,用于自动化治疗和远程患者监测平台。这个自动化平台将通过支持远程治疗锻炼和通过家庭设备进行远程治疗锻炼和社交参与度,可为使用实时功能的远程治疗锻炼和社交参与度提供每日疗法的访问,该设备可监视实时功能以适应基于云的数字内容以优化身体性能,认知,以及对运动和认知任务的身体响应。这种治疗系统的效率应与面对面的治疗和治疗课程相似,从而使急需的疗法可以同时降低PWP,家人和医疗保健系统的伯内斯。在整个会议中收集的主观报告数据,物理响应数据和客观绩效数据将在PWP,其家人以及他们的护理人员或医疗保健提供者的报告中总结,以改善患者的持续提供治疗,临床决策以及健康和安全性。这项提出的技术将有助于减少隔离的影响,提供物理疗法和运动治疗的影响,并改善整个Covid-19-19-19大流行危机及其他地区对患者的远程监控。这项奖项反映了NSF的法定任务,并被认为是通过基金会的知识分子优点和更广泛的影响审查标准来通过评估而被认为是珍贵的支持。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bennett Gatto其他文献
Bennett Gatto的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bennett Gatto', 18)}}的其他基金
SBIR Phase I: Engaging the Mind and Body: Technology to Automate Physical Therapy Treatments for Patients with Parkinson's Disease (PD).
SBIR 第一阶段:调动身心:为帕金森病 (PD) 患者提供自动化物理治疗的技术。
- 批准号:
1819997 - 财政年份:2018
- 资助金额:
$ 25.6万 - 项目类别:
Standard Grant
相似国自然基金
高层钢结构建模-优化-深化的跨阶段智能设计方法
- 批准号:52308142
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
游戏化mHealth干预模式下精神障碍出院患者自杀风险管理策略的实施科学研究——基于多阶段优化策略
- 批准号:72374095
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
非洲爪蟾IV型干扰素IFN-upsilon在不同发育阶段的抗病毒功能研究
- 批准号:32303043
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
壳斗科植物传播前阶段种子捕食的地理格局及其驱动机制
- 批准号:32371612
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
计及海量多元逆变资源下垂参数动态优化的配电网多阶段协调运行研究
- 批准号:52307091
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Kipiyecipakiciipe "coming home": Establishing clinical cultural neuroscience as a tool for understanding the role of traditional cultural engagement in mitigating substance misuse and disorder
Kipiyecipakiciipe“回家”:建立临床文化神经科学作为理解传统文化参与在减轻药物滥用和疾病中的作用的工具
- 批准号:
10740237 - 财政年份:2023
- 资助金额:
$ 25.6万 - 项目类别:
Identifying the Ideal Dose of Structured Summer Programming for Mitigating Accelerated Summer BMI Gain
确定结构化夏季计划的理想剂量,以缓解夏季体重指数加速增长
- 批准号:
10653609 - 财政年份:2023
- 资助金额:
$ 25.6万 - 项目类别:
Mitigating the Immunogenicity of Engineered Aav Gene Delivery Vectors by Biomaterial-Driven Immunosuppression
通过生物材料驱动的免疫抑制减轻工程化 Aav 基因递送载体的免疫原性
- 批准号:
10741139 - 财政年份:2023
- 资助金额:
$ 25.6万 - 项目类别:
mitoNEET as a therapeutic target for mitigating ischemic brain injury following MCAO
mitoNEET 作为减轻 MCAO 后缺血性脑损伤的治疗靶点
- 批准号:
10735923 - 财政年份:2023
- 资助金额:
$ 25.6万 - 项目类别:
Novel Pigment Sensing Pulse Oximeter Technology for Mitigating Racial Bias in Oxygen Saturation Measurements
新型颜料感应脉搏血氧仪技术可减少血氧饱和度测量中的种族偏见
- 批准号:
10599746 - 财政年份:2023
- 资助金额:
$ 25.6万 - 项目类别: